Ute Hoch,Christine Taylor Brew,Stephen David Harrison,Dennis G. Fry,Darren W. Davis
申请号：
US14292613
公开号：
US09863949B2
申请日:
2014.05.30
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Provided herein are methods directed to the prediction and early assessment of the efficacy of cancer treatment regimens, in particular in patients undergoing therapy with a DNA-damaging chemotherapeutic agent, by determining expression levels of certain proteins found to be useful as biomarkers in circulating tumor cells obtained from the patient both prior to and post-treatment.
